je.st
news
Tag: approves
World Bank approves funding for Turkey's renewable energy integration project
2014-05-13 01:00:00| Power Technology
The World Bank has approved $300m (217m) funding from the International Bank for Reconstruction and Development (IBRD) and $50m (36.2m) from the Clean Technology Fund (CTF) for Turkeys renewable energy integration project.
Tags: world
project
energy
bank
City manager approves Virgin America's move to Love Field
2014-05-12 22:40:05| Airlines - Topix.net
DALLAS After more than a week of formal consideration, Dallas City Manager A.C. Gonzalez approved Virgin America's lease of two gates at Love Field.
Alaska Air Group Approves $650 Million Share Repurchase Program
2014-05-12 16:25:45| Airlines - Topix.net
This share repurchase program represents approximately 10 percent of the market capitalization of the company.
FDA approves the Deka arm, the first commercial mind-controlled prosthetic arm
2014-05-12 15:45:11| Extremetech
The FDA has officially approved the first multi-input myoelectric artificial limb. The new Deka Arm System is designed to better replicate the full range of human function and was developed in conjunction with DARPA.
Tags: commercial
arm
fda
approves
FDA Approves ZONTIVITY (vorapaxar), First-in-Class PAR-1 Antagonist, for the Reduction of Thrombotic Cardiovascular Events in Patients with a History of Heart Attack or with Peripheral Arterial Disease
2014-05-12 13:30:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. ZONTIVITY Added to Standard of Care Demonstrated Long-Term Benefit Through Three Years WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved ZONTIVITY (vorapaxar) for the reduction of thrombotic cardiovascular events in patients with a history of heart attack (myocardial infarction) or in patients with narrowing of leg arteries, called peripheral arterial disease (PAD). Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558orPatrick Witmer, 267-305-4910orInvestors:Carol Ferguson, 908-423-4465orJustin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Sites : [255] [256] [257] [258] [259] [260] [261] [262] [263] [264] [265] [266] [267] [268] [269] [270] [271] [272] [273] [274] next »